DIA Europe 2019 has ended

Michael Schroter

Founding Partner
Michael is a managing partner at Viopas, a venture capital and asset management firm investing in privately held and listed companies with a sustainable healthcare focus. As such Viopas favours investments in solutions which deliver cost-effective and improved clinical outcomes. Prior to Viopas, Michael was head of personalized reimbursement models (PRM) at Roche, responsible for implementing value-based pricing approaches globally. He was chair of the EFPIA combination pricing working group. Before that role, Michael held various senior management positions in R&D and business development at Roche, Eli Lilly and in Biotech. Michael holds a PhD in biochemistry from the University of Lausanne and an MBA from IMD.